FDA found no violations at trial sites regarding Pfizer’s Lyme disease vaccine

A U.S. health regulator found no violations at clinical centres run by Care Access for Pfizer and French partner Valneva in a trial of a candidate vaccine against Lyme disease, a contract research firm.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM